Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)

被引：0
|
作者：
Fonseca, Vivian
Dejager, Sylvie
Albrecht, Diego
Shirt, Lynda
Schweizer, Anja
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [22] Health-related quality of life (HRQL) in patients with type 2 diabetes (T2DM), receiving add-on therapy with insulin glargine (GLAR) or pioglitazone (PIO)
    Oster, G.
    Meneghini, L. F.
    Schwartz, S.
    Zhang, Q.
    [J]. DIABETES, 2006, 55 : A477 - A477
  • [23] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [24] Empagliflozin as Add-On to Metformin Plus Sulfonylurea (SU) for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A279 - A279
  • [25] Empaglifl ozin (EMPA) Compared with Glimepiride (GLIM) as Add-On to Metformin (MET) for 4 Years in Patients with Type 2 Diabetes (T2DM)
    Ridderstrale, Martin
    Robert, Knut
    Toorawa, Andersen
    Woerle, Hans J.
    Salsali, Afshin
    [J]. DIABETES, 2016, 65 : A47 - A48
  • [26] Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
    Li, Feng-fei
    Shen, Yun
    Sun, Rui
    Zhang, Dan-feng
    Jin, Xing
    Zhai, Xiao-fang
    Chen, Mao-yuan
    Su, Xiao-fei
    Wu, Jin-dan
    Ye, Lei
    Ma, Jian-hua
    [J]. DIABETES THERAPY, 2017, 8 (05) : 1111 - 1122
  • [27] Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
    Feng-fei Li
    Yun Shen
    Rui Sun
    Dan-feng Zhang
    Xing Jin
    Xiao-fang Zhai
    Mao-yuan Chen
    Xiao-fei Su
    Jin-dan Wu
    Lei Ye
    Jian-hua Ma
    [J]. Diabetes Therapy, 2017, 8 : 1111 - 1122
  • [28] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    [J]. DIABETES, 2002, 51 : A102 - A102
  • [29] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Qiu, Ying
    Fu, Alex Z.
    Radican, Larry
    [J]. DIABETES, 2010, 59 : A604 - A604
  • [30] DAPAGLIFLOZIN: COST-EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES (T2DM) IN ARGENTINA AND CHILE
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Asteazaran, S.
    Aiello, E.
    Garrido Lecca, S.
    Alvarez, A.
    Roberts, M.
    Cortes Cuadra, P.
    Gagliardino, J. J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A248 - A248
12345